Navigating Sjogren's Syndrome: Guiding Patients in Their Care Journey

11/04/24 • 24 min

Listen as Elizabeth Kircher, DNP, and R. Hal Scofield, MD, discuss best practice approaches for the treatment of Sjögren’s syndrome and what’s on the horizon for future therapeutic options.

Topics include:

Challenges in Sjogren’s Syndrome Diagnosis and Patient Understanding: Difficulties in explaining Sjogren’s syndrome diagnosis to patients unfamiliar with it and challenges in addressing the disease’s varied symptoms
Patient Education and Communication: Strategies to prevent overwhelming patients during early visits and effective ways to address misconceptions
Diagnostic Challenges and Misunderstandings: Differences between clinical and research criteria for diagnosis and the importance of understanding each
Use of Ultrasound and Biopsy in Diagnosis: Benefits and limitations of ultrasound and biopsies in diagnosing Sjogren’s syndrome
Multidisciplinary Care Barriers: Challenges in coordinating care among specialists such as ophthalmologists, dentists, and rheumatologists
Symptomatic vs Disease-Modifying Treatments: Strategies for managing symptoms vs addressing the underlying disease with medications
Long-term Medication and Risks: Considerations when prescribing long-term medications and immunosuppressive therapies
Research and Emerging Therapies: Developments in Sjogren’s syndrome research, including promising medications in clinical trials
Guideline Development and Patient Reassurance: The role of professional guidelines in shaping care and providing patients with reassurance
Polypharmacy and Medication Reconciliation: The importance of pharmacist involvement in managing complex medication regimens for older patients

Faculty:

Elizabeth Kircher, DNP

R. Hal Scofield, MD
Member/Professor, Arthritis & Clinical Immunology
Oklahoma Medical Research Foundation
Professor, Department of Medicine, College of Medicine
University of Oklahoma Health Sciences Center
Associate Chief of Staff for Research
Oklahoma City US Department of Veterans Affairs Medical Center
Oklahoma City, Oklahoma

Link to full program:
https://bit.ly/3YKpsOE

Listen as Elizabeth Kircher, DNP, and R. Hal Scofield, MD, discuss best practice approaches for the treatment of Sjögren’s syndrome and what’s on the horizon for future therapeutic options.

Topics include:

Challenges in Sjogren’s Syndrome Diagnosis and Patient Understanding: Difficulties in explaining Sjogren’s syndrome diagnosis to patients unfamiliar with it and challenges in addressing the disease’s varied symptoms
Patient Education and Communication: Strategies to prevent overwhelming patients during early visits and effective ways to address misconceptions
Diagnostic Challenges and Misunderstandings: Differences between clinical and research criteria for diagnosis and the importance of understanding each
Use of Ultrasound and Biopsy in Diagnosis: Benefits and limitations of ultrasound and biopsies in diagnosing Sjogren’s syndrome
Multidisciplinary Care Barriers: Challenges in coordinating care among specialists such as ophthalmologists, dentists, and rheumatologists
Symptomatic vs Disease-Modifying Treatments: Strategies for managing symptoms vs addressing the underlying disease with medications
Long-term Medication and Risks: Considerations when prescribing long-term medications and immunosuppressive therapies
Research and Emerging Therapies: Developments in Sjogren’s syndrome research, including promising medications in clinical trials
Guideline Development and Patient Reassurance: The role of professional guidelines in shaping care and providing patients with reassurance
Polypharmacy and Medication Reconciliation: The importance of pharmacist involvement in managing complex medication regimens for older patients

Faculty:

Elizabeth Kircher, DNP

Link to full program:
https://bit.ly/3YKpsOE

Previous Episode

Paradigm Shifting Updates in IgAN: Expert Faculty Discussions of Recent Breakthroughs

In this CCO Nephrology podcast episode, hear from nephrologists Pietro Canetta, MD, MS, and Andy Bomback, MD, PhD, experts in clinical management and research on glomerular diseases as they discuss key updates in managing IgAN. Faculty highlight the importance of a comprehensive supportive care regimen to protect patients’ kidneys and prevent progression of disease. In addition, they review the merits and place in therapy of novel and emerging therapies.

Topics include:

Supportive care as the foundation of IgAN management
Place in therapy for new and emerging agents
- Targeted-release formulation of budesonide
- Endothelin receptor antagonists (eg, sparsentan)
- Factor B inhibitors (eg, iptacopan)
The role of clinical trial involvement

Learn more about IgA nephropathy with educational activities and resources here:

Next Episode

Recent Advances in PBC Management

In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including:

Treatment goals
Use of PPAR agonists for the treatment of PBC
Clinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO)

Presenter:

Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
University of California Davis School of Medicine
Sacramento, California

Link to full program:
https://bit.ly/41tvSDu

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.